Market Research Logo

Bio Techne Corp (TECH) - Financial and Strategic SWOT Analysis Review

Bio Techne Corp (TECH) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoassays, biologically active chemical compounds, and in situ genomic hybridization. It offers Western blot, enzyme-linked immunosorbent assay, and biologics platform. Bio Techne also offers controls and calibrators for hematology clinical instruments. Bio Techne’s products find application in scientific investigation of biological processes and also to identify the nature and progress of certain diseases. The company sells its products through an extensive network of distributors across the world. It caters to biotechnology research and clinical diagnostic markets. The company has subsidiaries in the UK, Canada, and China. Bio Techne is headquartered in Minneapolis, Minnesota, the US.

Bio Techne Corp Key Recent Developments

May 02,2018: Bio-Techne Releases Third Quarter Fiscal 2018 Results
Apr 26,2018: Bio-Techne Leads the Way in Scientific Support for Autophagy Research
Apr 24,2018: Bio-Techne Appoints Kim Kelderman As President, Diagnostics and Genomics
Mar 21,2018: Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) technology with the launch of several new and updated assays
Mar 14,2018: Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Bio Techne Corp - Key Facts
Bio Techne Corp - Key Employees
Bio Techne Corp - Key Employee Biographies
Bio Techne Corp - Major Products and Services
Bio Techne Corp - History
Bio Techne Corp - Company Statement
Bio Techne Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bio Techne Corp - Business Description
Business Segment: Biotechnology
Overview
Performance
Key Stats
Business Segment: Diagnostics
Overview
Performance
Key Stats
Business Segment: Protein Paltforms
Overview
Business Segment: Protein Platforms
Performance
Key Stats
Geographical Segment: APAC Excluding Greater China
Performance
Geographical Segment: EMEA Excluding the UK
Capital Expenditure
Geographical Segment: Greater China
Performance
Geographical Segment: Rest of world
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
Bio Techne Corp - Corporate Strategy
Bio Techne Corp - SWOT Analysis
SWOT Analysis - Overview
Bio Techne Corp - Strengths
Bio Techne Corp - Weaknesses
Bio Techne Corp - Opportunities
Bio Techne Corp - Threats
Bio Techne Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
Bio Techne Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018
Bio Techne Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 02, 2018: Bio-Techne Releases Third Quarter Fiscal 2018 Results
Apr 24, 2018: Bio-Techne Appoints Kim Kelderman As President, Diagnostics and Genomics
Mar 21, 2018: Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) technology with the launch of several new and updated assays
Mar 14, 2018: Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract
Feb 07, 2018: Bio-Techne Named RESEARCHERS' CHOICE by Citeab
Feb 06, 2018: Bio-Techne Reports Net Sales Of $154.2 million In The Second Quarter Of Fiscal 2018
Jan 30, 2018: Bio-Techne's Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms
Jan 15, 2018: Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne
Nov 20, 2017: Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design
Nov 14, 2017: Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Bio Techne Corp, Key Facts
Bio Techne Corp, Key Employees
Bio Techne Corp, Key Employee Biographies
Bio Techne Corp, Major Products and Services
Bio Techne Corp, History
Bio Techne Corp, Subsidiaries
Bio Techne Corp, Key Competitors
Bio Techne Corp, Ratios based on current share price
Bio Techne Corp, Annual Ratios
Bio Techne Corp, Annual Ratios (Cont...1)
Bio Techne Corp, Annual Ratios (Cont...2)
Bio Techne Corp, Interim Ratios
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
Bio Techne Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018
Bio Techne Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Bio Techne Corp, Performance Chart (2013 - 2017)
Bio Techne Corp, Ratio Charts
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
Bio Techne Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report